Connect with us

Health

Study confirms rare blood clotting risk linked to ChAdOx1-S vaccine – benefits still outweigh risks – News-Medical.Net

New research published in BMJ confirmed evidence of blood clotting finding a small risk after receiving one Oxford-AstraZeneca ChAdOx1-S severe acute respiratory…

Published

on

Article feature image

Pharmaceutical and biotechnology company AstraZeneca had recently come under fire for rare blood clotting events — causing a temporary suspension of the vaccine in multiple countries. In April, the European Medicines Agency concluded the vaccine is potentially linked to blood clotting in people with low blood platelets who received the dose. However, they emphasized unusual blood clotting was a rare side effect.
New research published in BMJ confirmed evidence of blood clotting finding a small risk…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
Article feature image
Covid-19 death after liver disease may reveal difference in care: study – Yahoo News Australia